![Mika Newton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mika Newton
Vorstandsvorsitzender bei xCures, Inc.
Profil
Mika Newton is the current Chief Executive Officer & Director at xCures, Inc. He previously worked as the General Manager-Clinical Development Services at Diadexus, Inc. in 2015.
He completed his undergraduate degree at Worcester Polytechnic Institute and the London School of Economics & Political Science.
Aktive Positionen von Mika Newton
Unternehmen | Position | Beginn |
---|---|---|
xCures, Inc.
![]() xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Vorstandsvorsitzender | 01.01.2019 |
Ehemalige bekannte Positionen von Mika Newton
Unternehmen | Position | Ende |
---|---|---|
DIADEXUS, INC. | Corporate Officer/Principal | - |
Ausbildung von Mika Newton
Worcester Polytechnic Institute | Undergraduate Degree |
London School of Economics & Political Science | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Diadexus, Inc.
![]() Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
xCures, Inc.
![]() xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Technology Services |